Combs Andrew
- SEC CIK
- 0001825005
No open-market purchases or sales filed in the past year.
Current role at each company
- PRLD Prelude Therapeutics IncChief Chemistry Officeras of Feb 5, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Combs Andrew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2025 (view filing) | Mar 25 | 2 days | Combs AndrewChief Chemistry Officer | PPurchase | +100.0K | $0.69 | +$69.0K | +26.3%480.1K after | |
| Dec 26, 2024 (view filing) | Dec 20-23 | 6 days | Combs AndrewChief Chemistry Officer | PPurchase | +63.1K | $1.36 | +$85.7K | +20.1%377.6K after | 2 lots |
| Dec 15, 2021 (view filing) | Dec 13-14 | 2 days | Combs AndrewEVP, Head of Chemistry | PPurchase | +8.00K | $11.86 | +$94.9K | +3.1%268.4K after | 2 lots |